ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,507Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 122

$574K Total Retail Price of All Prescriptions

Rank: 10 out of 122

737 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 737 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

7% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 10,238 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
LISINOPRIL 600 522 1 2
LEVOTHYROXINE SODIUM 504 439 2 4
HYDROCHLOROTHIAZIDE 502 463 3 6
SIMVASTATIN 465 389 4 1
OMEPRAZOLE 461 375 5 3
FUROSEMIDE 438 383 6 5
METOPROLOL SUCCINATE 379 346 7 11
METOPROLOL TARTRATE 322 285 8 8
AMLODIPINE BESYLATE 285 282 9 7
WARFARIN SODIUM 276 229 10 9
ATENOLOL 220 189 11 10
GABAPENTIN 218 151 12 12
PAROXETINE HCL 190 112 13 69
LOSARTAN POTASSIUM 171 153 14 17
LOVASTATIN 166 148 15 28
SERTRALINE HCL 162 148 16 18
ATORVASTATIN CALCIUM 161 150 17 13
HYDROCODONE-ACETAMINOPHEN 154 110 S3 18 16
TAMSULOSIN HCL 151 151 19 26
ZOLPIDEM TARTRATE 149 100 20 19
TRAZODONE HCL 147 131 21 21
METFORMIN HCL 142 112 22 14
POTASSIUM CHLORIDE 127 120 23 22
OXYCODONE-ACETAMINOPHEN 121 57 S2 24 41
OXYCODONE HCL 118 39 S2 25 30
ENALAPRIL MALEATE 115 115 26 43
QUETIAPINE FUMARATE 111 97 27 46
RANITIDINE HCL 106 92 28 39
OXYCONTIN 103 53 S2 29 87
DONEPEZIL HCL 102 102 30 25
FLUOXETINE HCL 96 91 31 38
LANTUS 95 59 32 36
AMITRIPTYLINE HCL 89 61 R 33 72
GLYBURIDE 88 85 R 34 73
DILTIAZEM 24HR CD 87 74 35 66
CLOPIDOGREL 84 77 36 45
MORPHINE SULFATE ER 84 0 S2 36 42
SPIRONOLACTONE 82 58 38 63
CITALOPRAM HBR 80 55 39 15
PANTOPRAZOLE SODIUM 79 63 40 23
DIOVAN 73 68 41 40
ADVAIR DISKUS 71 58 42 34
KLOR-CON M20 71 47 42 67
ALLOPURINOL 69 58 44 33
ALENDRONATE SODIUM 62 62 45 35
FENTANYL 59 57 S2 46 47
PREDNISONE 58 38 47 24
LIPITOR 57 51 48 82
OXYCODONE HCL-ACETAMINOPHEN 57 0 S2 48 113
NADOLOL 54 54 50 162
PROPRANOLOL HCL 54 34 50 114
DIGOXIN 53 53 52 74
METHADONE HCL 53 0 S2 52 69
AZITHROMYCIN 53 43 52 53
GLIPIZIDE 53 50 52 77
ISOSORBIDE MONONITRATE ER 53 53 52 44
SPIRIVA 52 47 57 29
FINASTERIDE 51 50 58 76
PROAIR HFA 51 37 58 31
COMBIVENT 50 30 60 60
CIPROFLOXACIN HCL 50 46 60 89
PEN NEEDLE 50 40 60 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.